We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-19.65%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$79.5M
AUM Growth
-$129M
Cap. Flow
+$5.75M
Cap. Flow %
7.23%
Top 10 Hldgs %
61.99%
Holding
120
New
40
Increased
18
Reduced
24
Closed
32

Top Buys

Rank Stock Value
1
SHIP icon
Seanergy Maritime Holdings
SHIP
+$3.88M
2
ATNM icon
Actinium Pharmaceuticals
ATNM
+$2.79M
3
SLS icon
SELLAS Life Sciences
SLS
+$2.79M
4
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.78M
5
RDGT
Ridgetech Inc
RDGT
+$2.6M

Top Sells

Rank Stock Value
1
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$2.41M
2
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$2.28M
3
LOOP icon
Loop Industries
LOOP
+$1.97M
4
BIIB icon
Biogen
BIIB
+$1.62M
5
ORMP icon
Oramed Pharmaceuticals
ORMP
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 36.62%
2 Industrials 1.78%
3 Technology 1.66%
4 Consumer Discretionary 1.42%
5 Real Estate 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMNN icon
76
Imunon
IMNN
$6.43M
$56K 0.07%
+158
New +$64.4K
CVM.WS
77
CALL
DELISTED
Cel-Sci Corp Series S
CVM.WS
$56K 0.07%
+100
New +$56K
NSPR icon
78
InspireMD
NSPR
$30.9M
$50K 0.06%
+987
New +$61.2K
SPHS
79
DELISTED
Sophiris Bio, Inc.
SPHS
$45K 0.06%
52,685
+19,042
+57% +$16.7K
CSCI
80
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$38K 0.05%
+128
New +$45.1K
IMNN icon
81
CALL
Imunon
IMNN
$6.43M
$23K 0.03%
1
– –
SGLBW
82
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$21K 0.03%
65,033
-23,434
-26% -$11K
ORMP icon
83
CALL
Oramed Pharmaceuticals
ORMP
$170M
$17K 0.02%
+489
New +$1.73K
PPBT
84
Purple Biotech
PPBT
$1.35M
$14K 0.02%
+7
New +$13.9K
SINT icon
85
SiNtx Technologies
SINT
$9.85M
– –
0
– –
FCEL icon
86
FuelCell Energy
FCEL
$1.61B
$3K ﹤0.01%
588
-83
-12% -$4.46K
AKAO
87
DELISTED
Achaogen Inc
AKAO
$3K ﹤0.01%
134,192
-214,208
-61% -$72.8K
BNTCW
88
DELISTED
Benitec Biopharma Limited
BNTCW
$1K ﹤0.01%
56,949
-1,000
-2% -$99
AQB icon
89
AquaBounty Technologies
AQB
$4.63M
– –
-12,802
Closed -$561K
BIIB icon
90
Biogen
BIIB
$31.8B
– –
-7,000
Closed -$1.62M
BIIB icon
91
PUT
Biogen
BIIB
$31.8B
– –
-148
Closed -$3.5M
BLRX
92
BioLineRX
BLRX
$12.3M
– –
-62
Closed -$16K
CRMD icon
93
CorMedix
CRMD
$564M
– –
-18,118
Closed -$142K
FCEL icon
94
PUT
FuelCell Energy
FCEL
$1.61B
– –
-1
Closed -$11K
KYNB
95
CALL
Kyntra Bio
KYNB
$28.2M
– –
-13
Closed -$1.83M
KYNB
96
Kyntra Bio
KYNB
$28.2M
– –
-528
Closed -$717K
KYNB
97
PUT
Kyntra Bio
KYNB
$28.2M
– –
-44
Closed -$5.95M
KPTI icon
98
CALL
Karyopharm Therapeutics
KPTI
$155M
– –
-24
Closed -$210K
KPTI icon
99
Karyopharm Therapeutics
KPTI
$155M
– –
-1,667
Closed -$146K
LOOP icon
100
Loop Industries
LOOP
$36.8M
– –
-248,436
Closed -$1.97M
1 2 3
4
5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sabby Management held 120 positions worth $79.5M, down 62% from $208M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sabby Management deployed $5.75M of net new capital in Q2 2019, opening 40 new positions and adding to 18 existing holdings. Its largest new stake was Seanergy Maritime Holdings: 10,437 shares worth $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Odonate Therapeutics, Inc. Common Stock, an estimated $2.41M trimmed.

  • Sabby Management's largest Q2 2019 buy was Seanergy Maritime Holdings: 10,437 shares worth $1.03M.
  • Sabby Management added most to Bridgeline Digital in Q2 2019, an estimated $625K increase.
  • Sabby Management's biggest Q2 2019 reduction was Odonate Therapeutics, Inc. Common Stock, cutting an estimated $2.41M.
  • Sabby Management fully exited Loop Industries in Q2 2019, selling an estimated $1.97M.
  • Sabby Management's ten largest holdings make up 62% of its $79.5M portfolio in Q2 2019.
  • Sabby Management opened 40 new positions and closed 32 in Q2 2019.
  • Sabby Management's portfolio value fell 62% quarter-over-quarter to $79.5M.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.